Hospital Owned By Conglomerate Martua Sitorus Sets IPO Price At IDR 1,280 Per Share, Targets To Raise IDR 325.14 Billion In Funds
Photo: Doc. Pure Teguh Hospital

JAKARTA - The hospital manager belonging to the conglomerate Martua Sitorus, PT Murni Sadar Tbk (MTMH) is ready to hold an initial public offering (IPO) on April 13-18 2022. The manager of the Murni Teguh Hospitals hospital set a price of Rp. 1,280 and released as many as 254,022,800 shares with a nominal value of Rp100 per share.

In an official statement, quoted on Tuesday, April 12, the target for obtaining funds from this corporate action is IDR 325.14 billion. Acting as the implementing underwriters for the issuance of securities are PT Ciptadana Sekuritas Asia and PT BCA Sekuritas.

All funds obtained from this public offering after deducting costs related to this public offering will be used around Rp. 20 billion for capital expenditures for business expansion. This is not limited to building renovations as well as purchasing medical equipment and supplies for a new hospital in Bandung with the name Rumah Murni Teguh Bandung.

Then, around Rp161 billion will be used for working capital needs, including but not limited to payment of trade debts, purchase of supplies in the form of goods used in the process of providing health services in hospitals such as drugs, medical devices and consumption materials, and payment of expenses. rent for the Pure Teguh Hospital building in Bandung.

Then, the rest will be loaned to subsidiaries. Around Rp 43.89 billion to pay off the entire principal loan of PT Murni Sadar Kasih Abadi (MSKA) from PT Bank Central Asia Tbk.

In the amount of Rp. 30 billion for capital expenditure in the context of MSKA's business expansion, including but not limited to the continued construction of the Pure Teguh Tuban Bali Hospital which has started its initial operational activities on December 12, 2021 as well as the construction of a new hospital in Pematang Siantar with the name Hospital Pure Teguh Pematang Siantar. The rest is for working capital needs.

The Company and its subsidiaries are health service providers with a focus on oncology and cardiovascular as well as health education centers. Currently, the company and its subsidiaries own five hospitals in Medan, Jakarta, Bali and Tangerang and operate one hospital in Medan using the operational cooperation method.

The five hospitals are Pure Teguh Memorial Hospital, Aminah Hospital, Pure Teguh Sudirman Hospital, Rosiva Mother and Child Hospital, and Pure Teguh Bali Hospital.

The total capacity of the company's five hospitals and subsidiaries as well as one hospital operated by the company is around 858 beds. As of December 31, 2021, the company and its subsidiaries employed 103 general practitioners and 319 specialists who offered services to the company's and subsidiaries' patients and approximately 1,980 nurses and other support staff.

Meanwhile, PT Murni Sadar Tbk has a close relationship with the conglomerate Martua Sitorus. In the row of shareholders of the company there is the name Jacqueline Sitorus who is the daughter of Martua Sitorus. Jacqueline holds 24.11 percent of Pure Sadar shares.

There is also the name of Andy Indigo who is the nephew of Martua Sitorus. At Murni Sadar, Andy is listed as the holder of 23.42 percent of the shares.

The following is the schedule for the public offering of PT Murni Sadar Tbk:

- Effective date: 11 April 2022- Public offering period: 13-18 April 2022- Allotment date: 18 April 2022- Electronic share distribution date: 19 April 2022- Share listing date on the Indonesia Stock Exchange: 20 April 2022


The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)